ADVERTISEMENT
ADVERTISEMENT
Researchers Who Discovered Hepatitis C Earn Nobel Prize
Researchers Who Discovered Hepatitis C Earn Nobel Prize
Harvey Alter, Michael Houghton, and Charles Rice share the Physiology or Medicine award for their contributions to identifying the virus and demonstrating that it was responsible for hepatitis among blood transfusion recipients.
Researchers Who Discovered Hepatitis C Earn Nobel Prize
Researchers Who Discovered Hepatitis C Earn Nobel Prize

Harvey Alter, Michael Houghton, and Charles Rice share the Physiology or Medicine award for their contributions to identifying the virus and demonstrating that it was responsible for hepatitis among blood transfusion recipients.

Harvey Alter, Michael Houghton, and Charles Rice share the Physiology or Medicine award for their contributions to identifying the virus and demonstrating that it was responsible for hepatitis among blood transfusion recipients.

hepatitis c

Shuping Wang, Public Health Whistleblower, Dies
Emily Makowski | Sep 30, 2019 | 2 min read
The physician and researcher challenged the Chinese government over her findings of widespread hepatitis and HIV contamination during blood collection.
Sofosbuvir Shows Anti-Zika Activity In Vitro
Marcia Triunfol | Jul 19, 2016 | 3 min read
Already approved for the treatment of hepatitis C, the drug appears to impair RNA-directed RNA polymerase activity in the virus.
Compatible Company
Amber Dance | Sep 1, 2015 | 8 min read
A guide to culturing cells with viruses in mind
Combatting Viruses with RNA-Targeted CRISPR
Amanda B. Keener | Apr 27, 2015 | 3 min read
Scientists reengineer a Cas9 enzyme that naturally targets bacterial RNA to stymie hepatitis C inside human cells.
Merck Snaps Up Biotech for $3.85B
Tracy Vence | Jun 10, 2014 | 1 min read
The drug giant will acquire Cambridge, Massachusetts-based Idenix Pharmaceuticals, which is focused on developing treatments for hepatitis C.
Study: Coffee Cuts Cancer Risk
Rina Shaikh-Lesko | Apr 10, 2014 | 1 min read
Evidence presented at AACR suggests that daily coffee consumption may cut a person’s risk of developing a form of liver cancer.
Viral in Valencia
Chris Palmer | Oct 1, 2013 | 4 min read
A genetic analysis that tracks the evolution of pathogens helped incriminate a Spanish anesthetist who infected hundreds of patients with hepatitis C.
Lab Tubes Contaminated with Virus
Kerry Grens | Sep 20, 2013 | 3 min read
A novel virus thought to have come from human samples appears to have been derived from seawater during the manufacture of tubes used to extract DNA.  
Phylogenetics Sheds Light on Crime
Kate Yandell | Jul 29, 2013 | 2 min read
Researchers reconstructed the evolutionary histories of hepatitis C virus samples to confirm that a Spanish anesthesiologist infected 275 of his patients.
The Organist
Megan Scudellari | May 1, 2013 | 9 min read
When molecular biology methods failed her, Sangeeta Bhatia turned to engineering and microfabrication to build a liver from scratch.
Canadian Scientist Declines Award
Kate Yandell | Mar 25, 2013 | 2 min read
A University of Alberta researcher refuses to accept a prestigious scientific award because he thought two of his collaborators should have also been honored.
Great Ape Research Decision
Kate Yandell | Mar 12, 2013 | 2 min read
The NIH will decide what to do with its research chimpanzees by the end of this month.
“Alive” and In Focus
Sarah Webb, Knowable Magazine | Oct 1, 2012 | 7 min read
Imaging viruses in action
Clinical Trial Misfortune
Cristina Luiggi | Aug 28, 2012 | 1 min read
A human trial of a hepatitis C treatment is shut down after one of the participants died.
PETA Buys Chimp Lab Stock
Tia Ghose | Dec 22, 2011 | 1 min read
The animal rights organization purchases shares of a research facility in a bid to end chimpanzee testing at the facility.
Drug Headlines of 2011
Hannah Waters | Dec 20, 2011 | 4 min read
A list of this year’s newsworthy successes—and failures—in drug development
hepatitis c lasker award
Six Scientists Receive Lasker Awards
Eugene Russo | Oct 15, 2000 | 7 min read
Ubiquitin-related research has made the transition from the basic to clinical arena in the past decade, and the field is now central to understanding diseases ranging from cancer to neurodegenerative disorders.
ADVERTISEMENT